SCHEMBL24038697

SCHEMBL24038697

CCOC(=O)C1c2ccc(S(=O)(=O)Cl)cc2CCN1C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 16/20 0.46
GPR119 Q8TDV5 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24031031 0.91 GPR119 (0.49) GHSRGPR119
SCHEMBL30920109 0.91 GHSR (0.45) GHSRGPR119
SCHEMBL24031466 0.91 GHSR (0.45) GHSRGPR119
SCHEMBL24038698 0.87 RORC (0.49) GHSRGPR119
SCHEMBL2085484 0.86 GHSR (0.44) GHSR
SCHEMBL2616991 0.86 GHSR (0.44) GHSR
SCHEMBL25895663 0.86 GHSR (0.46) GHSR
SCHEMBL17391103 0.85 GHSR (0.57) GHSR
SCHEMBL17391030 0.85 GHSR (0.54) GHSR
SCHEMBL2081445 0.85 ESR2 (0.49) GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192620-A1 ANILINE COMPOUND USED AS RORy REGULATOR SHANGHAI LITEDD CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192620-A1 ANILINE COMPOUND USED AS RORy REGULATOR SHANGHAI LITEDD CO., LTD. (CN) 2023-06-22 US disclosed
WO-2021228217-A1 ANILINE COMPOUND USED AS RORγ REGULATOR 上海辉启生物医药科技有限公司 2021-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192620-A1 ANILINE COMPOUND USED AS RORy REGULATOR RORB, RORA, RORC GHSR 691/4885GPR119 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.